Stay updated on CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdded revision v3.4.2 and removed revision v3.4.1 from the study's record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check15 days agoChange DetectedA new revision entry (v3.4.1) was added to the history, and outdated notices about funding and the older revision (v3.4.0) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check22 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status was added to the page.SummaryDifference0.8%

- Check29 days agoChange DetectedGlossary toggle and color-coded highlights were added, and the revision notice updated to v3.4.0; the No FEAR Act data line was removed.SummaryDifference1%

- Check36 days agoChange DetectedRecord History shows a new revision (v3.3.4) with sponsor Nanjing IASO Biotechnology Co., Ltd., and status notes such as 'Last known status was: Unknown status' and 'Verified'; the previous revision v3.3.3 appears to have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check65 days agoChange DetectedA new revision entry Revision: v3.3.3 was added to the record history, and the HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page.